Related Experiment Video
Updated: Dec 29, 2025

Endolymphatic Duct Blockage as a Surgical Treatment Option for Ménière's Disease
Published on: April 28, 2023
Value of Endolymphatic Hydrops and Perilymph Signal Intensity in Suspected Ménière Disease
J M van Steekelenburg1, A van Weijnen2, L M H de Pont3
1From the Departments of Radiology (J.M.v.S., L.M.H.d.P., S.H.) j.vansteekelenburg@hagaziekenhuis.nl.
Background And Purpose:
Ménière disease is characterized by endolymphatic hydrops, whereas perilymphatic enhancement on MR imaging has been suggested to be of additional value in diagnosing Ménière disease. This study evaluates the presence of endolymphatic hydrops and perilymphatic enhancement in patients with Ménière disease and with other vertigo-associated inner ear pathology.
Materials And Methods:
A 3D-FLAIR sequence 4 hours after intravenous gadolinium injection was performed to visualize the endolymph and perilymph in 220 patients suspected of having Ménière disease. Patients' ears were retrospectively categorized as having Ménière disease (probable or definite) or other vertigo-associated inner ear pathology not attributable to Ménière disease. Endolymphatic hydrops was evaluated using a visual classification system, and perilymphatic enhancement was scored both visually and quantitatively.
Results:
Endolymphatic hydrops was present in 137 (91.9%) of the definite Ménière disease ears and in 9 (7.0%) of the ears with other vertigo-associated inner ear pathology (P < .001). The combination of endolymphatic hydrops and visually increased perilymphatic enhancement was present in 122 (81.9%) definite Ménière disease ears compared with 4 (3.1%) ears with other vertigo-associated inner ear pathology (P < .001). This combination increases the positive predictive value from 0.94 for endolymphatic hydrops and 0.91 for perilymphatic enhancement to 0.97. The addition of measured perilymphatic enhancement leads to a moderate decrease in sensitivity from 0.92 for endolymphatic hydrops to 0.86.
Conclusions:
The combination of perilymphatic enhancement and endolymphatic hydrops in patients suspected of having Ménière disease increases the positive predictive value in the diagnosis of definite Ménière disease.
Insights
Combining endolymphatic hydrops and perilymphatic enhancement on MRI improves Ménière disease diagnosis. This dual imaging approach enhances diagnostic accuracy for definite Ménière disease in patients with vertigo.
Area of Science:
- Neurology
- Radiology
- Otolaryngology
Background:
- Ménière disease is characterized by endolymphatic hydrops.
- Perilymphatic enhancement on MRI may aid in Ménière disease diagnosis.
Purpose of the Study:
- Evaluate endolymphatic hydrops and perilymphatic enhancement in Ménière disease patients.
- Assess the diagnostic value of these findings in differentiating Ménière disease from other inner ear pathologies.
Main Methods:
- 220 patients with suspected Ménière disease underwent 3D-FLAIR MRI post-gadolinium injection.
- Endolymphatic hydrops and perilymphatic enhancement were assessed visually and quantitatively.
- Patients were categorized into definite Ménière disease or other inner ear pathology groups.
Main Results:
- Endolymphatic hydrops was found in 91.9% of definite Ménière disease cases.
- The combination of hydrops and enhanced perilymphatic enhancement was present in 81.9% of definite Ménière disease ears.
- This combination increased the positive predictive value to 0.97.
Conclusions:
- The combined presence of perilymphatic enhancement and endolymphatic hydrops improves the diagnosis of definite Ménière disease.
- This MRI finding combination offers significant diagnostic value for Ménière disease.
More Related Videos
11:49Surgical Induction of Endolymphatic Hydrops by Obliteration of the Endolymphatic Duct
Published on: January 22, 2010
10:27In Vivo Morphometric Analysis of Human Cranial Nerves Using Magnetic Resonance Imaging in Menière's Disease Ears and Normal Hearing Ears
Published on: February 21, 2018
Related Concept Videos
Mitral Regurgitation II: Clinical Features and Diagnostic Tests
Equilibrium and Balance
Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation